Genomic imbalances in CML blast crisis: 8q24.12–q24.13 Segment identified as a common region of over‐representation
- 22 April 2003
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 37 (4) , 346-358
- https://doi.org/10.1002/gcc.10173
Abstract
The acute phase of chronic myeloid leukemia (CML) is accompanied by secondary chromosomal changes. The additional changes have a non‐random pattern; however, highly abnormal (marker) chromosomes are reported in some 20% of abnormal karyotypes. These marker chromosomes have proved to be beyond the resolution of conventional G‐banding analysis. We used molecular cytogenetic techniques to determine the structure of complex chromosome markers in 10 CML‐derived cell lines after our investigations of CML patients in blast crisis. Multicolor fluorescence in situ hybridization identified a multitude of structural chromosome aberrations. In addition, genomic gains identified by comparative genomic hybridization (CGH) were mapped to highly complex marker chromosomes in more than one cell line. The most common genomic loss detected by CGH affected chromosome 9, whereas the most common genomic gains affected, in order of frequency, the sequences of 8q, 6, and 13q. The smallest discrete amplification on 8q was identified in cell line MEG‐01. This amplicon contains sequences represented by the marker D8S263/RMC08P029 but did not contain the proximal MYC gene or a more distal marker, D8S256/RMC08P025. We determined the size of the amplicon to be less than the chromosome segment 8q24.12–q24.13. The use of region‐ and locus‐specific probes to analyze the organization of highly complex marker structures aided the identification of preferentially amplified genomic regions. The resultant amplifications could harbor gene(s) driving disease progression.Keywords
This publication has 39 references indexed in Scilit:
- Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemiaBlood, 2001
- Screening for specific chromosome involvement in hematological malignancies using a set of seven chromosome painting probes: An alternative approach for chromosome analysis using standard FISH instrumentationCancer Genetics and Cytogenetics, 2000
- Telomere length shortening is associated with disease evolution in chronic myelogenous leukemiaAmerican Journal of Hematology, 1999
- EditorialLeukemia Research, 1999
- Comparative genomic hybridization is a powerful tool, complementary to cytogenetics, to identify chromosomal abnormalities in childhood acute lymphoblastic leukaemiaBritish Journal of Haematology, 1997
- Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotypingNature Genetics, 1997
- Establishment and Characterization of a New Ph1-Positive Chronic Myeloid Leukemia Cell Line MC3 with Trilineage Phenotype and an Altered p53 GeneLeukemia & Lymphoma, 1995
- In situ hybridisation analysis of a homogeneously staining region at 11q23–24 in an acute myeloid leukaemia (M5) using yeast artificial chromosomesGenes, Chromosomes and Cancer, 1993
- A new leukemia cell line with philadelphia chromosome characterized as basophil precursorsLeukemia Research, 1985
- A novel Ph1 chromosome positive cell line established from a patient with chronic myelogenous leukemia in blastic crisisLeukemia Research, 1985